RET-Mutant Medullary Thyroid Cancer
Medullary thyroid cancer (MTC) is a rare malignancy arising from parafollicular C-cells of the thyroid, accounting for approximately 3–4% of all thyroid cancers. RET mutations…
RET Fusion-Positive Solid Tumors
RET (REarranged during Transfection) gene fusions are oncogenic drivers identified across various solid tumor types. These fusions result in a chimeric oncoprotein combining the RET…
RET Fusion-Positive Thyroid Cancer
RET fusion-positive thyroid cancer represents a distinct molecular subset of differentiated thyroid cancers, predominantly papillary thyroid carcinoma (PTC) and poorly differentiated thyroid carcinoma (PDTC). RET…
RET Fusion-Positive Metastatic Non-Small Cell Lung Cancer
RET (Rearranged during Transfection) fusion-positive metastatic non-small cell lung cancer (NSCLC) represents a rare but clinically significant molecular subset of lung adenocarcinoma. RET gene fusions…